Eye-preserving therapy for retinoblastoma: new evidence and future perspectives

Affiliations

¹ Head Outreach Program, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona 08950, Spain; Fundación Pérez-Scremini Montevideo, Uruguay and Hospital Universitario Austral, Buenos Aires, Argentina. Electronic address: guillermoluis.chantada@sjd.es.

Editorial

Guillermo L Chantada. Lancet Child Adolesc Health. 2023 Sep.

. 2023 Sep;7(9):600-601.

doi: 10.1016/S2352-4642(23)00165-7. Epub 2023 Jul 31.

¹ Head Outreach Program, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona 08950, Spain; Fundación Pérez-Scremini Montevideo, Uruguay and Hospital Universitario Austral, Buenos Aires, Argentina. Electronic address: guillermoluis.chantada@sjd.es.

No abstract available

Conflict of interest statement

I declare no competing interests.

Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial.
Wen X, Fan J, Jin M, Jiang H, Li J, Han M, Zhang C, He X, Luo Y, Yang J, Zhou M, Tan J, Yang X, Ji X, Zhang J, Zhao J, Jia R, Fan X. Wen X, et al. Lancet Child Adolesc Health. 2023 Sep;7(9):613-620. doi: 10.1016/S2352-4642(23)00141-4. Epub 2023 Jul 31. Lancet Child Adolesc Health. 2023. PMID: 37536351